1,857
Views
46
CrossRef citations to date
0
Altmetric
Review

Neoadjuvant or adjuvant chemotherapy in early breast cancer?

, &
Pages 1071-1082 | Received 01 Jan 2020, Accepted 19 Mar 2020, Published online: 01 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Wei Jiang, Xiaofei Deng, Ting Zhu, Jing Fang & Jinyao Li. (2023) ABVS-Based Radiomics for Early Predicting the Efficacy of Neoadjuvant Chemotherapy in Patients with Breast Cancers. Breast Cancer: Targets and Therapy 15, pages 625-636.
Read now

Articles from other publishers (44)

Arvin Arian, Mohamad Ghazanfari Hashemi, Vahid Talebi, Nasrin AhmadiNejad, Bita Eslami, Nahid Sedighi & Ramesh Omranipour. (2023) Abbreviated breast MRI for evaluating breast cancer before initiation of neoadjuvant chemotherapy: A cross-sectional study. European Journal of Radiology Open 11, pages 100517.
Crossref
Yuxin Wang, Xiangling Ren, Yingjuan Zheng, Longfei Tan, Bingyan Li, Changhui Fu, Qiong Wu, Zengzhen Chen, Jun Ren, Daoke Yang, Shiping Yu & Xianwei Meng. (2023) Boosting Microwave Thermo‐Dynamic Cancer Therapy of TiMOF via COF‐Coating. Small 19:49.
Crossref
Christine Rogers, Adrienne N. Cobb, Jan I. C. Lloren, Lubna N. Chaudhary, Morgan K. Johnson, Chiang-Ching Huang, Mediget Teshome, Amanda L. Kong, Puneet Singh & Chandler S. Cortina. (2023) National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial. Breast Cancer Research and Treatment.
Crossref
Chen Liu, Xiaomei Huang, Xiaobo Chen, Zhenwei Shi, Chunling Liu, Yanting Liang, Xin Huang, Minglei Chen, Xin Chen, Changhong Liang & Zaiyi Liu. (2023) Use of Pretreatment Multiparametric MRI to Predict Tumor Regression Pattern to Neoadjuvant Chemotherapy in Breast Cancer. Academic Radiology 30, pages S62-S70.
Crossref
Amina Maimaitiaili, Heyan Chen, Peiling Xie, Zhenzhen Liu, Rui Ling, Yi Zhao, Hongjian Yang, Yunjiang Liu, Ke Liu, Jianguo Zhang, Dahua Mao, Zhigang Yu, Yinhua Liu, Peifen Fu, Jiandong Wang, Hongchuan Jiang, Zuowei Zhao, Xingsong Tian, Zhongwei Cao, Kejin Wu, Ailin Song, Feng Jin, Jianjun He, Zhimin Fan & Huimin Zhang. (2023) Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy. Journal of Cancer Research and Clinical Oncology 149:11, pages 8769-8778.
Crossref
Gilda Schmidt, Sebastian Findeklee, Gerda del Sol Martinez, Mihai-Teodor Georgescu, Christoph Gerlinger, Sogand Nemat, Gilbert Georg Klamminger, Meletios P. Nigdelis, Erich-Franz Solomayer & Bashar Haj Hamoud. (2023) Accuracy of Breast Ultrasonography and Mammography in Comparison with Postoperative Histopathology in Breast Cancer Patients after Neoadjuvant Chemotherapy. Diagnostics 13:17, pages 2811.
Crossref
Hongshi Ma, Hui Zhuang, Dong Zhai, Jinfu Wu, Jingge Ma, Zhiguang Huan & Chengtie Wu. (2023) Xonotlite Nanowire-Containing Bioactive Scaffolds for the Therapy of Defective Adipose Tissue in Breast Cancer. Nano Letters 23:15, pages 7157-7165.
Crossref
Ryan Margolis, Lokesh Basavarajappa, Junjie Li, Girgis Obaid & Kenneth Hoyt. (2023) Image-guided focused ultrasound-mediated molecular delivery to breast cancer in an animal model. Physics in Medicine & Biology 68:15, pages 155012.
Crossref
Akanksha Behl & Anil K. Chhillar. (2023) Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer. Recent Patents on Anti-Cancer Drug Discovery 18:3, pages 325-342.
Crossref
Anton A. Plekhanov, Ekaterina V. Gubarkova, Marina A. Sirotkina, Alexander A. Sovetsky, Dmitry A. Vorontsov, Lev A. Matveev, Sergey S. Kuznetsov, Alexandra Y. Bogomolova, Alexey Y. Vorontsov, Alexander L. Matveyev, Sergey V. Gamayunov, Elena V. Zagaynova, Vladimir Y. Zaitsev & Natalia D. Gladkova. (2023) Compression OCT-elastography combined with speckle-contrast analysis as an approach to the morphological assessment of breast cancer tissue. Biomedical Optics Express 14:6, pages 3037.
Crossref
Saba Shariati, Julia Lou, Lauren Milton, Tara Behroozian, Liying Zhang, Emily Lam, Gina Wong, Irene Karam & Edward Chow. (2023) Impact of adjuvant radiotherapy on patient-reported shortness of breath in patients with breast cancer using the ESAS. Journal of Medical Imaging and Radiation Sciences 54:2, pages 281-290.
Crossref
Christopher Johns, Steven K. Montalvo, M’Kay Cauble, Yu-Lun Liu, Sean All, Asal S. Rahimi, Prasanna G. Alluri, Marilyn Leitch, Nisha Unni, Rachel Wooldridge, Deborah Farr, Chika Nwachukwu & D. W. Nathan Kim. (2023) Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy. Breast Cancer Research and Treatment 199:2, pages 381-387.
Crossref
Kun Chen, Jian Wang, Shuai Li, Wen Zhou & Wengui Xu. (2023) Predictive value of 18F-FDG PET/CT-based radiomics model for neoadjuvant chemotherapy efficacy in breast cancer: a multi-scanner/center study with external validation. European Journal of Nuclear Medicine and Molecular Imaging 50:7, pages 1869-1880.
Crossref
Ina Mathilde Kjær, Søren Kahns, Signe Timm, Rikke Fredslund Andersen, Jonna Skov Madsen, Erik Hugger Jakobsen, Tomasz Piotr Tabor, Anders Jakobsen & Troels Bechmann. (2023) Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA. Scientific Reports 13:1.
Crossref
Shereen Akkila, Saba Shariati, Lauren Milton, Tara Behroozian, Liying Zhang, Julia Lou, Emily Lam, Gina Wong, Irene Karam & Edward Chow. (2023) Comparison of neoadjuvant versus adjuvant chemotherapy for breast cancer patients prior to receiving radiation therapy using Edmonton Symptom assessment system (ESAS) scores. Supportive Care in Cancer 31:4.
Crossref
Hongzhong Jin, Shichong Liao, Feng Yao, Juanjuan Li, Zhiliang Xu, Kailiang Zhao, Ximing Xu & Shengrong Sun. (2023) Insight into the Crosstalk between Photodynamic Therapy and Immunotherapy in Breast Cancer. Cancers 15:5, pages 1532.
Crossref
Tao He, Mingxing Hu, Shunyao Zhu, Meiling Shen, Xiaorong Kou, Xiuqi Liang, Lu Li, Xinchao Li, Miaomiao Zhang, Qinjie Wu & Changyang Gong. (2023) A tactical nanomissile mobilizing antitumor immunity enables neoadjuvant chemo-immunotherapy to minimize postsurgical tumor metastasis and recurrence. Acta Pharmaceutica Sinica B 13:2, pages 804-818.
Crossref
Ailin Qu, Qian Wang, Qing Chang, Jingkang Liu, Yongmei Yang, Xin Zhang, Yanli Zhang, Xiaoshi Zhang, Hongchun Wang & Yi Zhang. (2023) Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer. Scientific Reports 13:1.
Crossref
Rajesh Pradhan, Anuradha Dey, Rajeev Taliyan, Anu Puri, Sanskruti Kharavtekar & Sunil Kumar Dubey. (2023) Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer. Pharmaceutics 15:1, pages 246.
Crossref
Ismail Can Tercan, Baha Zengel, Ozlem Ozdemir, Demet Cavdar, Funda Tasli, Zehra Hilal Adibelli, Murat Karatas, Cenk Simsek, Isabel Raika Durusoy & Adam Uslu. (2023) The Oncologic Safety of Sentinel Lymph Node Biopsy in Patients with Node-Positive Breast Cancer with Complete Response to Neoadjuvant Chemotherapy: A Single-Center Experience. The Breast Journal 2023, pages 1-7.
Crossref
Kirti Amresh Gautam, Nimisha Singh, Priyanka Tyagi, Gunja Jha & Anushka Raman. (2023) Breast Cancer Associated Conventional and Advanced Therapies . International Journal of Pharmaceutical And Phytopharmacological Research 13:3, pages 22-37.
Crossref
Boya Lu, Elango Natarajan, Hanumantha Rao Balaji Raghavendran & Uma Devi Markandan. (2023) Molecular Classification, Treatment, and Genetic Biomarkers in Triple-Negative Breast Cancer: A Review. Technology in Cancer Research & Treatment 22, pages 153303382211452.
Crossref
Jida Chen, Lidan Jin, Lini Chen, Zilong Bian, Zhaoqing Li, Shuyin Cao, Jichun Zhou, Ling Xu, Wenhe Zhao & Qinchuan Wang. (2023) Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study. Cancer Treatment and Research Communications 36, pages 100719.
Crossref
R. L. Nussbaumer, N. Maggi, L. Castrezana, L. Zehnpfennig, F. D. Schwab, J. Krol, I. Oberhauser, W. P. Weber, C. Kurzeder, M. D. Haug & Elisabeth A. Kappos. (2022) The impact of neoadjuvant systemic treatment on postoperative complications in breast cancer surgery. Breast Cancer Research and Treatment 197:2, pages 333-341.
Crossref
Zixin Zhu, Hui Jiang, Jingling Xie, Xinrui Jin, Baolin Li & Jinbo Liu. (2022) Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta‑analysis. Scientific Reports 12:1.
Crossref
Marina K. Ibragimova, Matvey M. Tsyganov & Nikolai V. Litviakov. (2022) Whole Transcriptome Analysis of Breast Cancer Tumors during Neoadjuvant Chemotherapy: Association with Hematogenous Metastasis. International Journal of Molecular Sciences 23:22, pages 13906.
Crossref
Zheying Liu, Yinan Guan, Yongzhong Yao, Weijie Zhang, Xiaoming Zhuang, Yin Zhang & Tingting Zhu. (2022) Effectiveness and Safety of Zercepac and Reference Trastuzumab in the Neoadjuvant Setting for Early-Stage Breast Cancer: A Retrospective Cohort Study. Journal of Oncology 2022, pages 1-9.
Crossref
Luca Urso, Luigi Manco, Angelo Castello, Laura Evangelista, Gabriele Guidi, Massimo Castellani, Luigia Florimonte, Corrado Cittanti, Alessandro Turra & Stefano Panareo. (2022) PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review. International Journal of Molecular Sciences 23:21, pages 13409.
Crossref
Yueqiu Zhao, Licong Chen, Xiaoqing Zheng & Yulan Shi. (2022) Quality of life in patients with breast cancer with neoadjuvant chemotherapy: a systematic review. BMJ Open 12:11, pages e061967.
Crossref
Chia-Hua LiuJie-Ru YangI-Chen TsaiChiann-Yi HsuLum YeanChih-Chiang Hung. (2022) Comparison of overall survival after neoadjuvant and adjuvant chemotherapy in patients with early breast cancer with immediate breast reconstruction after mastectomy: A retrospective, matched case‑control study. Oncology Letters 24:6.
Crossref
Ying Nie, Yingjuan He, Jianzhi Wang, Hongjun Zhang & Junpeng Su. (2022) MRI Images-Based Evaluation of Efficacy of Neoadjuvant Chemotherapy for Breast Cancer and Its Effect on Depression and Immune Function of Patients. Contrast Media & Molecular Imaging 2022, pages 1-8.
Crossref
Jida Chen, Lidan Jin, Lini Chen, Zilong Bian, Zhaoqing Li, Shuyin Cao, Jichun Zhou, Ling Xu, Wenhe Zhao & Qinchuan Wang. (2022) Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: a comparative study. Cancer Treatment and Research Communications, pages 100618.
Crossref
Keng-Shiang Huang, Yi-Ting Wang, Omkar Byadgi, Ting-Yu Huang, Mi-Hsueh Tai, Jei-Fu Shaw & Chih-Hui Yang. (2022) Screening of Specific and Common Pathways in Breast Cancer Cell Lines MCF-7 and MDA-MB-231 Treated with Chlorophyllides Composites. Molecules 27:12, pages 3950.
Crossref
Zhiming Fan, Honggui He & Liqun Chen. (2022) The Combined Clinical Efficacy and Safety Analysis of Adoptive Immunotherapy with Radiotherapy and Chemotherapy in Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis. Applied Bionics and Biomechanics 2022, pages 1-8.
Crossref
Fengchang Zhu, Chengyin Liu, Huaji Zhang & Liping Bai. (2022) Efficacy and Safety of Albumin-bound Paclitaxel Versus Solvent-based Paclitaxel in Breast Cancer: A Meta-analysis. Journal of Modern Nanotechnology 2:1.
Crossref
Xiaoyu Zhang, Huixin Li, Feng Wu, Dan Sun, Hengle Zhang, Lijun Jin, Xiaoning Kang & Zunyi Wang. (2022) Neoadjuvant Chemotherapy Combined with Breast-Conserving Surgery in the Treatment of Triple-Negative Breast Cancer. Journal of Oncology 2022, pages 1-6.
Crossref
Zihan Zhang, Qian Lin, Yi Chen, Chenlin Su, Wuye Lin, Daoyu Wei, Litu Zhang & Haizhou Liu. (2022) Prognostic Evaluation of Metastasis-Related Lymphocyte/Monocyte Ratio in Stage Ⅰ-Ⅲ Breast Cancer Receiving Chemotherapy. Frontiers in Oncology 11.
Crossref
Ana Isabel Fraguas-Sánchez, Irene Lozza & Ana Isabel Torres-Suárez. (2022) Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic. Cancers 14:5, pages 1198.
Crossref
Paola Ferrari, Cristian Scatena, Matteo Ghilli, Irene Bargagna, Giulia Lorenzini & Andrea Nicolini. (2022) Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC. International Journal of Molecular Sciences 23:3, pages 1665.
Crossref
Jinguo Zhang, Shuaikang Pan, Chen Jian, Li Hao, Jie Dong, Qingqing Sun, Hongwei Jin & Xinghua Han. (2022) Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice. Frontiers in Immunology 12.
Crossref
Shanshan Deng, Tingyou Zhang, Xi Chen, Junhua Shi, Mi Meng, Guojun Yue, Shiyun Xing, Xin Tian, Xiaorong Yang, Fang Chen & Ning Li. (2021) Is there a correlation between miR-301a expression and neoadjuvant chemotherapy efficacy in breast cancer tissue?. Biochemistry and Biophysics Reports 26, pages 100947.
Crossref
Yaqing Liu, Zhaoyang Huang, Sujuan Yang, Cuiyun Zhou & Mei Chen. (2021) Perioperative management of wounds with nanosilver dressing after neoadjuvant chemotherapy for breast cancer. Materials Express 11:6, pages 912-919.
Crossref
Cinzia Solinas, Debora Fumagalli & Maria Vittoria Dieci. (2021) Immune Checkpoint Blockade in HER2-Positive Breast Cancer: What Role in Early Disease Setting?. Cancers 13:7, pages 1655.
Crossref
Li Chen, Xuantong Zhou, Xiangyi Kong, Zhaohui Su, Xiangyu Wang, Sen Li, Aiping Luo, Zhihua Liu, Yi Fang & Jing Wang. (2021) The Prognostic Significance of Anisomycin-Activated Phospho-c-Jun NH2-Terminal Kinase (p-JNK) in Predicting Breast Cancer Patients’ Survival Time. Frontiers in Cell and Developmental Biology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.